Graham Capital Management, L.P. - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
Graham Capital Management, L.P. ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$781,957
-77.2%
28,812
-74.2%
0.02%
-81.8%
Q2 2023$3,436,916
+504.0%
111,806
+608.0%
0.10%
+482.4%
Q1 2023$568,985
-79.7%
15,792
-77.8%
0.02%
-80.0%
Q4 2022$2,808,725
+332.8%
71,071
+340.0%
0.08%
+226.9%
Q3 2022$649,000
-62.5%
16,154
-63.7%
0.03%
-56.7%
Q1 2022$1,732,000
+720.9%
44,459
+736.2%
0.06%
+566.7%
Q4 2021$211,0005,3170.01%
Other shareholders
ROYALTY PHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders